InterContinental Hotels Group PLC Announces Transaction in Own Shares - Jun 05
InterContinental Hotels Group PLC (the Company) Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / June 5, 2024 / The Company announces that on 04 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Argo Blockchain PLC Announces May Operational Update, TVR and New Shares
LONDON, ENGLAND / ACCESSWIRE / June 5, 2024 / Argo Blockchain plc, a global leader in cryptocurrency mining (LSE:ARB)(NASDAQ:ARBK), is pleased to provide the following operational update for May 2024. During the month of May, the Company mined 45 Bitcoin or Bitcoin Equivalents (together, "BTC"), or 1.5 BTC per day.
Angle PLC Announces Preliminary Results
Preliminary Results for the year ended 31 December 2023 COMMERCIALISATION BUILDING, WITH REVENUE MORE THAN DOUBLED New products and services launched; and breakthrough studies completed on combined ctDNA and CTC-DNA analysis Strong start to 2024 with two global pharmaceutical customers announced GUILDFORD, SURREY / ACCESSWIRE / June 5, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, today announces unaudited preliminary results for the year ended 31 December 2023. Financial Highlights Revenues for the full year more than doubled to £2.2 million (2022: £ 1.0 million) Loss for the year £20.1 million, or 7.73 pence per share (2022: loss £21.7 million or 8.79 pence per share) Cash and cash equivalents at 31 December 2023 of £16.2 million (2022: £31.9 million) with R&D Tax Credits due at 31 December 2023 of £1.5 million (2022: £2.9 million) Fundraise announced today raising £8.50 million (gross) with an Open Offer to shareholders initiated raising up to £2.06 million Operational Highlights Pharma Services Contracts signed with new and repeat customers including: services agreement signed at year end and announced early 2024 with global Japanese pharma company, Eisai, for use of ANGLE's quantitative HER2 assay in a Phase II trial new contract with Crescendo Biologics to use ANGLE's Portrait Flex assay in a Phase I clinical study in prostate cancer follow-on contract with Artios Pharma for use of DNA Damage Response (DDR) assays in a Phase I clinical trial in multiple advanced cancers Launch of Portrait Flex, Portrait DDR (γH2AX and pKAP1), and Portrait PD-L1 assays from the Company's GCLP-compliant laboratory Products Expansion of global distribution network and associated infrastructure (including product management, logistics, service, and maintenance) across Europe, Africa, the Middle East and Asia-Pacific with first commercial sales in fourth quarter Launch of Portrait+ CTC Staining Kit as first sample-to-answer product providing laboratories with a fully validated, standardised protocol for CTC identification and analysis across multiple cancer types Strategic partnership with BioView to develop a quantitative breast cancer CTC HER2 assay kit.
InterContinental Hotels Group PLC Announces Transaction in Own Shares – Jun 4
LONDON, UNITED KINGDOM / ACCESSWIRE / June 4, 2024 / The Company announces that on 03 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Genflow Biosciences PLC Announces Notice of AGM
Genflow Biosciences Plc Notice of Annual General Meeting LONDON, UNITED KINGDOM / ACCESSWIRE / June 3, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that it will hold its Annual General Meeting ("AGM") at 12pm on Thursday 27 June 2024 at 1 Heddon Street, London, W1B 4BT. The Notice of the AGM ("Notice") and 2024 Form of Proxy will shortly be available on the Company's website, www.genflowbio.com, and have, where applicable, been posted to shareholders.
Hemogenyx Pharmaceuticals PLC Announces Posting of Annual Report & Notice of AGM
Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company") Posting of Annual Report & Notice of Annual General Meeting LONDON, UNITED KINGDOM / ACCESSWIRE / June 3, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group, confirms that the Annual Report and Accounts for the year ended 31 December 2023, the Notice of the Annual General Meeting ("AGM") and a Form of Proxy will be posted to shareholders today and are available on the Company's website at Click Here The AGM is to be held on 27 June 2024 at 2.00 pm BST at the offices of SP Angel Corporate Finance LLP, Prince Frederick House, 35-39 Maddox Street, London W1S 2PP.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Jun 03
InterContinental Hotels Group PLC (the Company) Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / June 3, 2024 / The Company announces that on 31 May 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Diversified Energy Company PLC (DEC) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw Diversified Energy Company PLC (DEC) settling at $15.15, representing a -0.72% change from its previous close.
Flutter Entertainment PLC Announces Transition to US Primary Listing Complete
DUBLIN, IRELAND / ACCESSWIRE / May 31, 2024 / Flutter's primary listing now on the New York Stock Exchange. Flutter Entertainment plc ("Flutter" or the "Company") (NYSE:FLUT)(LSE:FLTR) announced today that its primary listing is now on the New York Stock Exchange ("NYSE").
Ecora Resources PLC Announces Completion of U$10 million Buyback Programme
LONDON, UNITED KINGDOM / ACCESSWIRE / May 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that following the purchase of ordinary shares on 30 May 2024, the Company's share buyback programme (the "Programme"), as announced on 27 March 2024, has been completed. Over the course of the Programme, the Company has acquired in aggregate 9,491,317 ordinary shares of 2 pence each in the Company (the "Ordinary Shares") between 27 March 2024 and 30 May 2024 for a total consideration of U$10 million, at a volume weighted average price of approximately 83.77 pence per share.
InterContinental Hotels Group PLC Announces Transaction in Own Shares – May 31
LONDON, UNITED KINGDOM / ACCESSWIRE / May 31, 2024 / The Company announces that on 30 May 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Ecora Resources PLC Announces Transaction in Own Shares
LONDON, UNITED KINGDOM / ACCESSWIRE / May 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that on 30 May 2024, it purchased 91,503 ordinary shares of 2p each in the Company (the "Shares") on the London Stock Exchange through Peel Hunt LLP, in accordance with the terms of its share buyback programme announced on 27 March 2024 (the "Programme"). The Shares acquired will be held in treasury.
